EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling post-vaccination proteomic signatures in SARS-CoV-2 infection-naïve individuals associated with Omicron breakthrough infections

Yiwen Liu iD, Eric Lu iD, Katherine D Ellingson, James Hollister, Tuo Liu iD, Wadana Hamzazai iD, Shawn C Beitel, Alberto J Caban-Martinez iD, Manjusha Gaglani, Allison L Naleway, Lauren E W Olsho iD, Andrew L Phillips und 5 weitere

PLOS One · 11.05.2026 · 21 (5) · e0347602

DOI: 10.1371/journal.pone.0347602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 11.05.2026. Verfasst von Yiwen Liu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, United States …. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Proteome, COVID-19 Vaccines. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Immunization and Respiratory Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Given the persistence of the SARS-CoV-2 virus, it is important to understand the proteome associated with breakthrough infections among COVID-19 vaccinated individuals.

Methods

We conducted a nested case-control study within the frontline worker HEROES-RECOVER cohorts to specify a study population of SARS-CoV-2 infection-naïve participants who had a third dose of COVID-19 origin strain WA-1 monovalent mRNA vaccine from August 2021 to January 2022. We compared serum proteomic profiles for those who subsequently experienced Omicron breakthrough infections with those of matched controls without infections. Our study leveraged proteomics data generated from the SomaScan Platform and adopted a robust feature selection method, elastic net regularized conditional logistic regression with bootstrapping, to identify key proteins. Enrichment analyses were performed to investigate biological pathways.

Results

We identified 28 significant proteins out of over 7,000 candidate proteins. Key findings included downregulated chemokines (CXCL2, CXCL3, CCL19, CCL23) and elevated cytokine IL-7 levels in breakthrough cases, with pathway analysis revealing enrichment in chemokine signaling and cytokine-cytokine interaction pathways. Other key proteins, such as LGALS1, HAVCR2, and SELE were upregulated in breakthrough cases.

Discussion

These results reveal potential immune response mechanisms in breakthrough infections, characterized by viral immune evasion and compensatory T-cell regeneration. The identified biomarkers may provide valuable insights for future predictive profiles and therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2ProteomeCOVID-19 VaccinesHumansProteomicsCase-Control StudiesBreakthrough InfectionsVaccinationMaleFemaleAdult

Substanzen

ProteomeCOVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, United States of America.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
  • Department of Community, Environment and Policy, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, United States of America.
  • Department of Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, United States of America.
  • Baylor Scott and White Health, Temple, Texas and Baylor College of Medicine, Temple Texas, United States of America.
  • Kaiser Permanente Center for Health Research, Portland, Oregon, United States of America.

ORCID-Profile: Yiwen Liu, Eric Lu, Tuo Liu, Wadana Hamzazai, Alberto J Caban-Martinez, Lauren E W Olsho, Jefferey L Burgess

Förderung

  • National Center for Immunization and Respiratory Diseases

Zitieren

APA

Liu, Y., Lu, E., Ellingson, K. D., Hollister, J., Liu, T., Hamzazai, W., Beitel, S. C., Caban-Martinez, A. J., Gaglani, M., Naleway, A. L., Olsho, L. E. W., Phillips, A. L., Solle, N. S., Tyner, H. L., Yoon, S. K., Lutrick, K., & Burgess, J. L. (2026). Unveiling post-vaccination proteomic signatures in SARS-CoV-2 infection-naïve individuals associated with Omicron breakthrough infections. PLOS One, 21(5), e0347602. https://doi.org/10.1371/journal.pone.0347602

Vancouver

Liu Y, Lu E, Ellingson KD, Hollister J, Liu T, Hamzazai W, et al. Unveiling post-vaccination proteomic signatures in SARS-CoV-2 infection-naïve individuals associated with Omicron breakthrough infections. PLOS One. 2026;21(5):e0347602. doi:10.1371/journal.pone.0347602

BibTeX
@article{Liu2026,
  author = {Liu, Yiwen and Lu, Eric and Ellingson, Katherine D and Hollister, James and Liu, Tuo and Hamzazai, Wadana and Beitel, Shawn C and Caban-Martinez, Alberto J and Gaglani, Manjusha and Naleway, Allison L and Olsho, Lauren E W and Phillips, Andrew L and Solle, Natasha Schaefer and Tyner, Harmony L and Yoon, Sarang K and Lutrick, Karen and Burgess, Jefferey L},
  title = {Unveiling post-vaccination proteomic signatures in SARS-CoV-2 infection-naïve individuals associated with Omicron breakthrough infections},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {5},
  pages = {e0347602},
  doi = {10.1371/journal.pone.0347602}
}
Kostenlos starten →